Los Angeles Capital Management
ZURA icon

Los Angeles Capital Management’s Zura Bio ZURA Stock Holding History

Los Angeles Capital Management’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99.8K Buy
+16,916
New +$80.6K ﹤0.01% 1346

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Los Angeles Capital Management's ZURA Position: Q2 2026 in Review

Los Angeles Capital Management opened a new position in Zura Bio (ZURA) in Q2 2026: 16,916 shares worth $99.8K. The stake represents ﹤0.01% of the portfolio and ranks #1346 among its holdings.

95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Los Angeles Capital Management held 16,916 shares of Zura Bio worth $99.8K as of Q2 2026.
  • Zura Bio was a new Los Angeles Capital Management position in Q2 2026.
  • Zura Bio made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #1346 holding.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.